SCHEMBL9364477

SCHEMBL9364477

CCOC(=O)C(=O)Nc1cc(C#N)c(Cl)cc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 5/20 0.55
ALDH1A1 P00352 3/20 0.53
GAA P10253 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KMT2A Q03164 2/20 0.50
AKR1B1 P15121 1/20 0.47
LMNA P02545 4/20 0.45
MAPT P10636 2/20 0.43
HTT P42858 1/20 0.42
GLA P06280 1/20 0.42
BRAF P15056 1/20 0.41
RECQL P46063 1/20 0.41
GALR2 O43603 1/20 0.40
MITF O75030 1/20 0.40
POLB P06746 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HPGD P15428 1/20 0.40
XBP1 P17861 1/20 0.40
CCR6 P51684 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9365594 0.91 ALDH1A1 (0.57) GPR35ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL4706310 0.87 ALDH1A1 (0.57) GPR35ALDH1A1L3MBTL1KMT2AAKR1B1
SCHEMBL9364473 0.86 LMNA (0.51) GPR35L3MBTL1KMT2ALMNAMAPT
SCHEMBL9365150 0.85 ALDH1A1 (0.52) GPR35ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL9364628 0.81 ALDH1A1 (0.50) GPR35ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL1192392 0.80 HTT (0.62) ALDH1A1L3MBTL1KMT2ALMNAMAPT
SCHEMBL9364681 0.80 GPR35 (0.55) GPR35ALDH1A1KMT2AAKR1B1LMNA
SCHEMBL8892134 0.79 GPR35 (0.57) GPR35ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL9365451 0.79 GPR35 (0.60) GPR35ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL9363972 0.79 ALDH1A1 (0.64) GPR35ALDH1A1KMT2AAKR1B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed